J. Caujolle

发表

Dose-response and normal tissue complication probabilities after proton therapy for choroidal melanomas.

J. Thariat, J. Herault, J. Kiilgaard, 2020, Ophthalmology.

Small but Challenging Conjunctival Melanoma: New Insights, Paradigms and Future Perspectives

C. Bertolotto, P. Hofman, S. Baillif, 2021, Cancers.

Swept-source and spectral domain OCT imaging of conjunctival tumors.

S. Baillif, S. Lassalle, C. Maschi, 2020, Ophthalmology.

Conjunctival melanomas and proton beam therapy

P. Gastaud, J. Caujolle, J. Doyen, 2013, Acta ophthalmologica.

Multicenter, International Assessment of the Eighth Edition of the American Joint Committee on Cancer Cancer Staging Manual for Conjunctival Melanoma

B. Gallie, H. Heimann, B. Damato, 2019, JAMA ophthalmology.

Dose-response and normal tissue complication probabilities after proton therapy for choroidal melanomas Dose response after proton therapy for choroidal melanoma

J. Thariat, J. Kiilgaard, A. Appelt, 2021 .

Dry Eye Syndrome After Proton Therapy of Ocular Melanomas.

J. Thariat, J. Salleron, J. Herault, 2017, International journal of radiation oncology, biology, physics.

Outcomes After Proton Beam Therapy for Large Choroidal Melanomas in 492 Patients.

J. Thariat, J. Herault, S. Baillif, 2016, American journal of ophthalmology.

Ultra‐widefield fundus photography for radiation therapy planning of ocular tumours

J. Thariat, J. Herault, L. Kodjikian, 2020, Acta ophthalmologica.

Visual Outcomes of Parapapillary Uveal Melanomas Following Proton Beam Therapy.

J. Thariat, J. Herault, W. Sauerwein, 2016, International Journal of Radiation Oncology, Biology, Physics.

Clinical Investigation : Central Nervous System Tumor Local Recurrence After Uveal Melanoma Proton Beam Therapy : Recurrence Types and Prognostic Consequences

P. Gastaud, J. Herault, E. Chamorey, 2022 .

Proton beam radiotherapy for uveal melanomas at nice teaching hospital: 16 years' experience.

P. Gastaud, J. Herault, E. Chamorey, 2010, International journal of radiation oncology, biology, physics.

OCT-angiography for the diagnosis of radiation maculopathy in patients treated with proton beam therapy: A 2-year prospective study

S. Baillif, C. Maschi, J. Caujolle, 2021, European journal of ophthalmology.

Quantification of dose perturbations induced by external and internal accessories in ocular proton therapy and evaluation of their dosimetric impact.

J. Thariat, J. Herault, W. Sauerwein, 2013, Medical physics.

New concepts in the diagnosis and management of choroidal metastases

J. Thariat, L. Kodjikian, C. Mosci, 2019, Progress in Retinal and Eye Research.

The molecular pathology of eye tumors: A 2019 update Main interests for routine clinical practice.

P. Hofman, S. Baillif, S. Lassalle, 2019, Current molecular medicine.

Management of Invasive Squamous Cell Carcinomas of the Conjunctiva.

J. Thariat, J. Salleron, J. Herault, 2019, American journal of ophthalmology.

[Surgery and additional protontherapy for treatment of invasive and recurrent squamous cell carcinomas: technique and preliminary results].

P. Gastaud, J. Herault, P. Chauvel, 2009, Journal francais d'ophtalmologie.

Oncologic and visual outcomes after postoperative proton therapy of localized conjunctival melanomas

J. Thariat, J. Salleron, J. Herault, 2019, Radiation Oncology.

Conjunctival melanoma copy number alterations and correlation with mutation status, tumor features, and clinical outcome

H. Heimann, B. Damato, A. Taktak, 2019, Pigment cell & melanoma research.

Conjunctival melanoma treatment outcomes in 288 patients: a multicentre international data-sharing study

B. Gallie, H. Heimann, B. Damato, 2020, British Journal of Ophthalmology.

Tumour Response in Uveal Melanomas Treated with Proton Beam Therapy.

J. Thariat, J. Herault, C. Maschi, 2016, Clinical oncology (Royal College of Radiologists (Great Britain)).

Optimizing the treatment of liver metastases from uveal melanomas with transarterial chemoembolization using melphalan and calibrated microspheres.

J. Thariat, J. Salleron, P. Chevallier, 2020, Bulletin du cancer.

Single-cell RNA sequencing reveals intratumoral heterogeneity in primary uveal melanomas and identifies HES6 as a driver of the metastatic disease

K. Bille, C. Bertolotto, R. Ballotti, 2021, Cell Death & Differentiation.

Single-cell RNA sequencing reveals intratumoral heterogeneity in 3 primary uveal melanomas and identi fi es HES 6 as a driver of the 4 metastatic disease

K. Bille, C. Bertolotto, R. Ballotti, 2021 .

Diagnosis and treatment of peripheral exudative haemorrhagic chorioretinopathy

G. Quentel, J. Thariat, R. Tadayoni, 2019, British Journal of Ophthalmology.

Cataract Avoidance With Proton Therapy in Ocular Melanomas.

J. Thariat, J. Salleron, J. Herault, 2017, Investigative ophthalmology & visual science.

COMPARATIVE EFFECTIVENESS OF PROTON BEAM VERSUS PHOTODYNAMIC THERAPY TO SPARE THE VISION IN CIRCUMSCRIBED CHOROIDAL HEMANGIOMA.

J. Thariat, J. Salleron, J. Herault, 2020, Retina.

Mechanisms of phosphenes in irradiated patients

J. Thariat, J. Herault, L. Kodjikian, 2017, Oncotarget.

INTRAVITREAL DEXAMETHASONE 0.7-MG IMPLANT FOR RADIATION MACULAR EDEMA AFTER PROTON BEAM THERAPY FOR CHOROIDAL MELANOMA

P. Gastaud, S. Baillif, C. Maschi, 2013, Retina.

The Lens Opacities Classification System III Grading in Irradiated Uveal Melanomas to Characterize Proton Therapy-Induced Cataracts.

J. Thariat, J. Salleron, J. Herault, 2019, American journal of ophthalmology.

Proton Beam Therapy for Iris Melanomas in 107 Patients.

J. Thariat, J. Salleron, J. Herault, 2017, Ophthalmology.

Inverted conjunctival papilloma: a certainly underestimated high-risk lesion for carcinomatous transformation-a case report.

P. Hofman, V. Giordanengo, S. Lassalle, 2017, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie.

[Management of uveal melanomas, guidelines for oncologists].

L. Desjardins, J. Thariat, J. Herault, 2018, Bulletin du cancer.

The Small Fatal Choroidal Melanoma Study. A Survey by the European Ophthalmic Oncology Group.

L. Desjardins, T. Kivelä, M. Jager, 2019, American journal of ophthalmology.

Occurrence of Phosphenes in Patients Undergoing Proton Beam Therapy for Ocular Tumor.

J. Thariat, J. Herault, L. Kodjikian, 2018, American journal of ophthalmology.

Phosphenes in patients receiving radiotherapy.

J. Thariat, J. Herault, S. Baillif, 2016, The Lancet. Oncology.

Management of choroidal metastases.

J. Thariat, P. Marcy, J. Herault, 2014, Cancer treatment reviews.

["Melanoma 92". epidemiological study of uveal melanoma in France].

L. Desjardins, P. Chauvel, É. Albuisson, 1995, Journal francais d'ophtalmologie.

Visual Outcomes of Parapapillary Uveal Melanomas Following Proton Beam Therapy.

J. Thariat, J. Herault, W. Sauerwein, 2016, International journal of radiation oncology, biology, physics.

[Management of uveal melanomas, guidelines for oncologists].

L. Desjardins, J. Thariat, J. Herault, 2018, Bulletin du cancer.

Results of proton therapy of uveal melanomas treated in Nice.

P Gastaud, P Chauvel, J Hérault, 1999, International journal of radiation oncology, biology, physics.